PTPN12 and breast carcinoma: In addition, several studies have shown that PTPN12 is linked to a favorable prognosis in TNBC patients by suppressing multiple oncogenic tyrosine kinases, including HER2 and EGFR, thereby dampening breast cancer cell survival, migration and EMT (150–152).